Semaglutide vs Tirzepatide for PCOS
PCOS affects 1 in 10 women and is closely linked to insulin resistance. Here is how the two leading GLP-1 medications compare for managing PCOS symptoms.
Medical Disclaimer: PCOS management requires comprehensive care. GLP-1 medications are not FDA-approved specifically for PCOS. Consult your gynecologist or endocrinologist.
Polycystic ovary syndrome is fundamentally a metabolic disorder driven by insulin resistance. That makes GLP-1 medications a compelling treatment option. Both semaglutide and tirzepatide address the root cause of PCOS, but their approaches differ.
Why GLP-1 Works for PCOS
- Insulin resistance: The core driver of PCOS in most women. Both medications improve insulin sensitivity
- Weight loss: Even modest weight loss (5-10%) can restore ovulation, reduce androgens, and improve symptoms
- Androgen reduction: Improved insulin sensitivity reduces ovarian androgen production, improving acne and hirsutism
- Inflammation: GLP-1 medications reduce systemic inflammation, which contributes to PCOS pathology
Head-to-Head for PCOS
| PCOS Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Insulin resistance improvement | Good | Superior |
| Weight loss (key for PCOS) | ~15% | ~21% |
| A1C improvement | Good | Superior |
| Reproductive safety data | More published data | Less published data |
| Must stop before conception | Yes (2+ months) | Yes (2+ months) |
PCOS, Fertility, and GLP-1
For women with PCOS trying to conceive, GLP-1 medications can be transformative but require careful timing:
- Use GLP-1 medication to achieve weight loss and improve insulin resistance
- Stop medication at least 2 months before attempting conception
- The metabolic improvements from weight loss persist after stopping medication
- Many women with PCOS spontaneously ovulate after achieving 5-10% weight loss
- If pursuing IVF, see our GLP-1 before IVF guide
The Bottom Line
Our Assessment
Tirzepatide may have a slight advantage for PCOS due to superior insulin resistance improvement and greater weight loss. However, semaglutide is also highly effective and has more published reproductive safety data. Both are excellent tools for managing PCOS when combined with lifestyle modifications. Work closely with your gynecologist or endocrinologist.
Frequently Asked Questions
Which GLP-1 is better for PCOS?
Tirzepatide may have an edge for PCOS due to superior improvements in insulin resistance, which is the core metabolic driver of PCOS. However, both medications can produce the 5-10% weight loss that significantly improves PCOS symptoms. The best choice depends on your full health profile.
Can GLP-1 restore ovulation in PCOS?
Yes. Weight loss of 5-10% can restore regular ovulation in many women with PCOS. Both semaglutide and tirzepatide can achieve this level of weight loss. However, GLP-1 medications should be stopped before attempting conception.
Will GLP-1 help with PCOS acne and hair growth?
By improving insulin resistance and reducing androgen levels through weight loss, GLP-1 medications can improve PCOS-related acne and hirsutism over time. These changes typically take 3-6 months to become noticeable as hormone levels normalize.
Can I take GLP-1 with metformin for PCOS?
Yes. Many PCOS patients take GLP-1 medications alongside metformin. The two drugs work through different mechanisms and can be complementary. However, combining them may increase GI side effects. Your provider will determine the right combination for you.
Address the Root Cause of PCOS
Trimi offers affordable GLP-1 treatment to help manage PCOS through weight loss and metabolic improvement.
Get Started TodayMore on Micro-Comparisons
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).